Class 1 anti-dysrhythmic medications and cardiac glycosides (CV) Flashcards
Anti-dysrhythmics: General overview
-Classified as the Vaughan Williams classification
-Cardiac Action Potential in relation to NSR
Class I antidysrhythmic effects
-Membrane-stabilizing drugs
-Fast sodium channel blockers
Class Ia anti dysrhythmic drugs
-Disopryramide
-Quinidine
-Procainamide
-“mide” & “dine”; DQP
Class Ia anti dysrhythmic MOA
-Blocks Na+ channels
-Delays repolarization and prolongs action potential duration
-Affects phase 0
Class Ia anti-dysrhythmic effects
-Depress myocardial excitability, inotropic effect & ectopic foci stimulation
-Prolong refractory period
Class Ia anti-dysrhythmic indications
-Atrial fibrillation
-Premature contractions & ventricular tach
-Wolff-Parkinson-White syndrome
Class Ia anti-dysrhythmics: procainamide adverse effects
-Agranulocytosis
-SLE-like syndrome
Class Ia anti-dysrhythmic adverse events: quinidine
-Prolonged QT
-Anorexia
-Bitter taste, blurred vision, tinnitus
Class Ib anti-dysrhythmic drugs
-Lidocaine
-Mexiletine
-Phenytoin
Class Ib anti-dysrhythmic MOA
-Block Na+ channels
-They accelerate repolarization and decrease the action potential duration
Class Ib anti-dysrhythmic effects
-Decrease ventricular excitability
Class Ib anti-dysrhythmic indications
Ventricular dysrhythmias only:
-PVC, v-tach, v-fib
Class Ib anti-dysrhythmic adverse events: Lidocaine
-Bradycardia
-Metallic taste
Class Ic anti-dysrhythmic MOA
-Block Na+ channels
-Suppresses re-entry
-“C” suppress
Class Ic anti-dysrhythmic drugs
-Flecainide
-Propafenone
-PF
Class Ic anti-dysrhythmic effects
-Depression of conduction in the bundle of his-Purkinje system
-Have minimal effect on atrial conduction
-Flecainide: Reserved for the most serious dysrhythmias
Class Ic anti-dysrhythmic indications
-V-Tach, SVT, A fib, atrial flutter
-Wolff-Parkinson-White syndrome
Class Ic anti-dysrhythmic adverse events: Flecainide
-Dyspnea, dizziness
-Palpitations
-Visual disturbances
-N/V, diarrhea, weakness
Class Ic anti-dysrhythmics: propafenone (effect, indications & adverse effects)
-Prodysrythmic effect, angina, tachycardia, AV block
-Dizziness, dyspnea, fatigue
Class II anti-dysrhythmics: beta-blocker drugs
-Metoprolol
-Esmolol
-Acebutalol
-“lols”
Class II anti-dysrhythmics: beta blockers MOA
-Reduces spontaneous depolarization
-Block impulse transmission
-Affects phase 4
Class II anti-dysrhythmic: beta blocker effects
-Blocks beta-adrenergic heart stimulation
-Decrease atrial stimulation & ventricular contraction rate
-Decrease CO & BP
Class II anti-dysrhythmics: beta blockers indications
-SVT
-Ventricular dysrhythmias